Johnson & Johnson exceeds expectations with strong financial results and impressive sales growth. Read more to see why I am ...
Johnson & Johnson reported mixed first-quarter results on Tuesday, with adjusted earnings surpassing Wall Street's ...
The company is benefiting from a rebound in demand for nonurgent surgeries among older adults, who deferred those procedures ...
I was diagnosed with ovarian cancer, my life has been a nightmare," Pat Matthey testified in 2018. Her son is suing Johnson & ...
Johnson & Johnson (JNJ) is poised for growth with solid financials, a consistent dividend streak, and the potential for ...